Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702220 | Practical Radiation Oncology | 2016 | 7 Pages |
Abstract
HDR IOBT with Ir-192 via VATS is technically feasible and safe for intrathoracic disease with pleural and/or limited chest wall involvement. Short-term morbidity associated with chest wall resection may be reduced. Additional study is required to define long-term benefits.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Daniel J. MD, MPH, Sai MD, FACS, Mark MD, Jorge MD, Harish PhD, DABR, Lalith PhD, DABR, Iris PhD, Todd MD,